Hydrofarm Group (HYFM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Net sales declined 28.4% year-over-year to $39.2 million in Q2 2025, driven by industry oversupply and lower product volumes.
Achieved 12th consecutive quarter of year-over-year adjusted SG&A savings, reducing expenses by nearly 16% compared to 2024.
Initiated a new restructuring plan to optimize product portfolio, focus on higher-margin proprietary brands, and target over $3 million in annual cost savings.
Delivered positive free cash flow of $1.4 million for the quarter through disciplined working capital and inventory management.
Net loss narrowed to $16.9 million from $23.5 million year-over-year, with SG&A expense reductions offsetting some margin pressure.
Financial highlights
Q2 2025 net sales were $39.2 million, down 28.4% year-over-year, mainly due to a 27.9% decline in volume mix.
Gross profit was $2.8 million (7.1% of net sales), down from $10.9 million (19.8%) last year, impacted by $3.3 million in restructuring charges.
Adjusted gross profit was $7.5 million (19.2% of net sales), compared to $13.3 million (24.4%) last year.
Adjusted EBITDA was a loss of $2.3 million, with sequential improvement from Q1 2025.
Cash and equivalents stood at $11.0 million as of June 30, 2025; net debt was $111.6 million.
Free cash flow for the quarter was $1.4 million.
Outlook and guidance
Reaffirmed full-year 2025 guidance for improved adjusted gross profit margin and reduced adjusted SG&A expense.
Expects positive free cash flow and inventory reduction for the final nine months of 2025.
Anticipates annual cost savings in excess of $3 million from restructuring, with one-third of benefits realized in H2 2025.
Plans incremental marketing investments in H2 2025 to boost proprietary brand performance.
Cited ongoing industry headwinds and tariff uncertainties as potential risks to performance.
Latest events from Hydrofarm Group
- Sales dropped 13% and net loss widened, but positive adjusted EBITDA and outlook reaffirmed.HYFM
Q2 20242 Feb 2026 - Gross margin improved to 19.4% as net loss narrowed and 2024 outlook was reaffirmed.HYFM
Q3 202416 Jan 2026 - Sales and profit fell in 2024, but cost cuts and brand mix support margin and cash flow gains in 2025.HYFM
Q4 202424 Dec 2025 - Shelf registration enables up to $50M in securities for growth and strategic flexibility.HYFM
Registration Filing16 Dec 2025 - Director elections, executive pay, and auditor ratification headline the 2025 annual meeting.HYFM
Proxy Filing1 Dec 2025 - Proxy statement covers annual meeting proposals and confirms no major capital changes.HYFM
Proxy Filing1 Dec 2025 - Annual proxy statement details routine voting matters for shareholders.HYFM
Proxy Filing1 Dec 2025 - Sales and margins fell 25% as industry headwinds and restructuring drove guidance withdrawal.HYFM
Q1 202526 Nov 2025 - Sales fell 33% and margins declined as restructuring and leadership changes continued.HYFM
Q3 202512 Nov 2025